PT Capsugel Indonesia (Indonesia)

Capsugel Indonesia is primarily engaged in gelatin capsules activity. Its headquarters is located in Jawa Barat. The company was founded in 1996. Capsugel Indonesia is a subsidiary of Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions to the pharmaceutical and health nutrition industries. Capsugel was originally founded by Pfizer in 1931 and later acquired by Lonza Group in 2017, a Swiss multinational chemicals and biotechnology company. The primary business line of Capsugel Indonesia is the manufacturing of gelatin capsules, which are used extensively in the pharmaceutical industry for encapsulating medications and supplements. The company also engages in secondary activities such as the production of vegetarian capsules and other specialized dosage forms. Capsugel Indonesia operates several manufacturing facilities in Indonesia, contributing to its strong local presence. The company is part of Lonza's global network, which spans over 30 countries, allowing it to leverage international expertise and resources. Capsugel's product portfolio includes a wide range of capsule types, such as hard gelatin capsules, liquid-filled capsules, and specialized capsules designed for targeted drug delivery. The company is known for its innovative brands like Coni-Snap® and Vcaps® Plus, which are recognized for their quality and reliability. Capsugel Indonesia collaborates with various pharmaceutical companies and research institutions to advance capsule technology and improve drug delivery systems. The company is a member of several industry associations, reflecting its commitment to maintaining high standards and staying at the forefront of industry developments. With a focus on innovation and customer satisfaction, Capsugel Indonesia aims to enhance the efficacy and safety of pharmaceutical products, contributing to better health outcomes globally.